Answers are grounded in this paper and cite their sources.
A short-term delay in PAH targeted therapy may adversely affect functional capacity in patients with PAH. This meta-analysis provides some insight as to whether earlier treatment would benefit stable patients with PAH.
No takes yet. Share an insight, caveat, or question.
Vizza et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: